Pharmaceuticals And Chemicals Travancore Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 21-12-2024
- Paid Up Capital ₹ 3.50 M
as on 21-12-2024
- Company Age 72 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.33 Cr
as on 21-12-2024
- Satisfied Charges ₹ 1.41 M
as on 21-12-2024
- Revenue 133.59%
(FY 2021)
- Profit 122.25%
(FY 2021)
- Ebitda 731.47%
(FY 2021)
- Net Worth 5.73%
(FY 2021)
- Total Assets 2.32%
(FY 2021)
About Pharmaceuticals And Chemicals Travancore
The Corporate was formerly known as Pharmaceuticals And Chemicals Travancore Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹7.33 Cr. The company has closed loans amounting to ₹1.41 M, as per Ministry of Corporate Affairs (MCA) records.
Mohandas Rani and Devan Mohan serve as directors at the Company.
- CIN/LLPIN
U24231KL1952PTC000945
- Company No.
000945
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jun 1952
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Pharmaceuticals And Chemicals Travancore?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohandas Rani  | Director | 01-Sep-1994 | Current |
| Devan Mohan | Director | 22-Feb-2016 | Current |
Financial Performance of Pharmaceuticals And Chemicals Travancore.
Pharmaceuticals And Chemicals Travancore Pvt Ltd, for the financial year ended 2021, experienced significant growth in revenue, with a 133.59% increase. The company also saw a substantial improvement in profitability, with a 122.25% increase in profit. The company's net worth moved up by a moderate rise of 5.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmaceuticals And Chemicals Travancore?
In 2021, Pharmaceuticals And Chemicals Travancore had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 17 Mar 2021 | ₹4.00 M | Open |
Canara Bank Creation Date: 11 Jun 2020 | ₹7.93 M | Open |
Canara Bank Creation Date: 18 Jan 2020 | ₹1.00 Cr | Open |
How Many Employees Work at Pharmaceuticals And Chemicals Travancore?
Unlock and access historical data on people associated with Pharmaceuticals And Chemicals Travancore, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmaceuticals And Chemicals Travancore, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmaceuticals And Chemicals Travancore's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
